Finance

Beta
Lists
DOD:BKK
DOD Biotech PCL
THB 1.64
0.00%
(0.00) 1D
Jun 2, 4:40:00 PM GMT+7  ·   THB
All symbols
SymbolPriceChange% Change
Generating top insights for DOD...
Open
THB 1.62
High
THB 1.67
Low
THB 1.62
Mkt. cap
738.68M
Avg. vol.
383.46K
Volume
245.41K
52-wk high
THB 2.32
52-wk low
THB 1.45
Shares outstanding
450.41M
No. of employees
431
Open
THB 1.62
High
THB 1.67
Low
THB 1.62
Mkt. cap
738.68M
Avg. vol.
383.46K
Volume
245.41K
52-wk high
THB 2.32
52-wk low
THB 1.45
Shares outstanding
450.41M
No. of employees
431
News stories
From sources across the web
About DOD Biotech PCL
CEO-
Employees431
FoundedFeb 11, 2011
Headquarters-
SectorPersonal care products
Previous reportsAll values in THB
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in THB
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
153.07M
149.98M
144.94M
122.55M
Cost of goods sold
98.87M
91.35M
96.77M
93.32M
Cost of revenue
98.87M
91.35M
96.77M
93.32M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
44.38M
48.64M
46.27M
41.73M
Operating expense
44.38M
48.64M
46.27M
49.95M
Total operating expenses
143.26M
139.99M
143.05M
143.27M
Operating income
9.81M
9.99M
1.89M
-20.72M
Other non operating income
-
-
-
226.00K
EBT including unusual items
9.75M
12.25M
1.67M
-21.40M
EBT excluding unusual items
9.74M
9.72M
1.56M
-21.40M
Income tax expense
-350.00K
1.96M
-10.99M
-1.17M
Effective tax rate
-3.59%
15.98%
-657.37%
5.46%
Other operating expenses
-
-
-
8.23M
Net income
9.58M
10.02M
12.78M
-21.87M
Net profit margin
6.26%
6.68%
8.82%
-17.85%
Earnings per share
-
-
-
-
Interest and investment income
617.00K
496.00K
588.12K
-
Interest expense
-695.00K
-767.00K
-913.06K
-899.00K
Net interest expenses
-78.00K
-271.00K
-324.94K
-899.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
20.39M
20.62M
11.30M
-9.56M
Gain or loss from assets sale
142.00K
11.00K
-2.05K
247.00K
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more